DDAH2 Antibody Summary
| Immunogen |
Peptide with sequence SSLCLVLSTRPHS corresponding to C-Terminus according to NP_039268.1.
|
| Clonality |
Polyclonal
|
| Host |
Goat
|
| Gene |
DDAH2
|
| Purity |
Immunogen affinity purified
|
| Innovators Reward |
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
|
Applications/Dilutions
| Dilutions |
|
|
| Application Notes |
WB: Approx. 28 kDa band observed in human lung lysates (calculated MW of 29.6 kDa band according to NP_039268.1).
|
|
| Publications |
|
Reactivity Notes
Predicted cross-reactivity based on sequence identity: Rat, Canine, Bovine.
Packaging, Storage & Formulations
| Storage |
Store at -20C. Avoid freeze-thaw cycles.
|
| Buffer |
0.5 mg/ml Tris (pH 7.3) and 0.5% BSA
|
| Preservative |
0.02% Sodium Azide
|
| Concentration |
0.5 mg/ml
|
| Purity |
Immunogen affinity purified
|
Alternate Names for DDAH2 Antibody
- DDAHII
- dimethylargininase-2
- dimethylarginine dimethylaminohydrolase 2G6a
- dimethylarginine dimethylaminohydrolase II
- EC 3.5.3.18
- G6a
- N(G)
- N(G)-dimethylarginine dimethylaminohydrolase 2
- NG30
- NG-dimethylarginine dimethylamino hydrolase homolog
- S-phase protein
Background
DDAH2 plays a role in nitric oxide generation by regulating cellular concentrations of methylarginines, which in turn inhibit nitric oxide synthase activity. Overexpression of DDAH2 has also been linked to increased VEGF mRNA expression and enhanced tube formation by cells grown in a 3-dimensional medium.